
Opinion|Videos|November 25, 2025
The Burden and Unmet Needs Associated with Desmoid Tumors
Patients with desmoid tumors face significant clinical and economic burdens, impacting their quality of life and leading to ongoing treatment challenges.
Advertisement
Panelists discuss the questions below in this video.
- There any molecular biomarkers that are commonly associated with desmoid tumor?
- What is the role of biomarker testing in patients with suspected diagnosis? What makes the definitive diagnosis?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
RSV Vaccination Effective in Older Adults, but Protection Declines Over Time
2
Older Adults Drive Hospitalizations, Costs in the US 2024-2025 Influenza Season
3
Discontinuing GLP-1s Before or Early in Pregnancy Tied to Weight Gain, Pregnancy Complications
4
Tapinarof Shows Strong Efficacy, Sleep Benefits in Pediatric AD Across Comorbidities: Druhan Howell, MD
5














































